{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T06:00:19Z","timestamp":1781416819271,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"VitreoRetinal Surgery Foundation"},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005242","name":"Heed Ophthalmic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mayocp.2018.11.033","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T07:01:16Z","timestamp":1561964476000},"page":"1287-1295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma"],"prefix":"10.1016","volume":"94","author":[{"given":"Gena M.","family":"Damento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2009-3163","authenticated-orcid":false,"given":"Jose S.","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9710-4284","authenticated-orcid":false,"given":"Lauren A.","family":"Dalvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mayocp.2018.11.033_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","article-title":"Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey","volume":"119","author":"Aggarwal","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.mayocp.2018.11.033_bib2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1745-7254.2008.00889.x","article-title":"Tumor necrosis factor and cancer, buddies or foes?","volume":"29","author":"Wang","year":"2008","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.mayocp.2018.11.033_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1634\/theoncologist.2009-0325","article-title":"Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety","volume":"15","author":"Moreno-Ramirez","year":"2010","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.mayocp.2018.11.033_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrrheum.2013.134","article-title":"Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales","volume":"9","author":"Ioannidis","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"19","key":"10.1016\/j.mayocp.2018.11.033_bib7","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mayocp.2018.11.033_bib8","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mayocp.2018.11.033_bib9","first-page":"241","article-title":"TNF-alpha inhibitors: are they carcinogenic?","volume":"2","author":"Raval","year":"2010","journal-title":"Drug Healthc Patient Saf"},{"issue":"11","key":"10.1016\/j.mayocp.2018.11.033_bib10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.mayocp.2014.08.012","article-title":"Clinical and histologic findings in patients with uveal melanomas after taking tumor necrosis factor-alpha inhibitors","volume":"89","author":"Damento","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"suppl5","key":"10.1016\/j.mayocp.2018.11.033_bib11","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaad.2006.12.024","article-title":"Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies","volume":"56","author":"Fulchiero","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2018.11.033_bib12","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/bjd.12779","article-title":"Melanoma associated with tumour necrosis factor-alpha inhibitors: a Research on Adverse Drug events And Reports (RADAR) project","volume":"170","author":"Nardone","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mayocp.2018.11.033_bib13","doi-asserted-by":"crossref","first-page":"f1939","DOI":"10.1136\/bmj.f1939","article-title":"Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden","volume":"346","author":"Raaschou","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.mayocp.2018.11.033_bib14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000355670","article-title":"Nodal melanoma metastasis under infliximab therapy in a patient with nevoid melanoma first misdiagnosed as benign nevus: a potentially dangerous diagnostic pitfall in the era of biologic therapies","volume":"5","author":"Safa","year":"2013","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.mayocp.2018.11.033_bib15","first-page":"195","article-title":"Development of primary malignant melanoma during treatment with a TNF-alpha antagonist for severe Crohn's disease: a case report and review of the hypothetical association between TNF-alpha blockers and cancer","volume":"7","author":"Kouklakis","year":"2013","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"10.1016\/j.mayocp.2018.11.033_bib16","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/2012.jama.10857","article-title":"Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis","volume":"308","author":"Lopez-Olivo","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mayocp.2018.11.033_bib17","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/art.30310","article-title":"Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"63","author":"Thompson","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.mayocp.2018.11.033_bib18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/ard.2008.091025","article-title":"The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events","volume":"68","author":"Leombruno","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2018.11.033_bib19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/annrheumdis-2017-212613","article-title":"Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors","volume":"77","author":"Beukelman","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2018.11.033_bib20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.mayocp.2012.04.018","article-title":"Melanoma in immunosuppressed patients","volume":"87","author":"Kubica","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocp.2018.11.033_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mayocp.2018.11.033_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.mayocp.2018.11.033_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/CMR.0b013e328322fc20","article-title":"Immunosuppression and melanocyte proliferation","volume":"19","author":"Zattra","year":"2009","journal-title":"Melanoma Res"},{"issue":"12","key":"10.1016\/j.mayocp.2018.11.033_bib24","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.mayocp.2018.11.033_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1634\/theoncologist.11-4-397","article-title":"TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility","volume":"11","author":"van Horssen","year":"2006","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.mayocp.2018.11.033_bib26","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/ard.2010.149419","article-title":"Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis","volume":"70","author":"Mariette","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2018.11.033_bib27","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/art.22864","article-title":"Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mayocp.2018.11.033_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12348-014-0026-8","article-title":"Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders","volume":"4","author":"Pascual-Camps","year":"2014","journal-title":"J\u00a0Ophthalmic Inflamm Infect"},{"issue":"10","key":"10.1016\/j.mayocp.2018.11.033_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2018.11.033_bib30","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s12032-009-9348-z","article-title":"Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review","volume":"27","author":"Dillon","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.mayocp.2018.11.033_bib31","series-title":"SEER Cancer Statistics Review","year":"1975"},{"issue":"3","key":"10.1016\/j.mayocp.2018.11.033_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul Oncol Pathol"},{"issue":"19","key":"10.1016\/j.mayocp.2018.11.033_bib33","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/onc.2013.194","article-title":"Melanoma metastasis: new concepts and evolving paradigms","volume":"33","author":"Damsky","year":"2014","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.mayocp.2018.11.033_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/pcmr.12304","article-title":"Biology of advanced uveal melanoma and next steps for clinical therapeutics","volume":"28","author":"Luke","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"issue":"10","key":"10.1016\/j.mayocp.2018.11.033_bib35","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.4049\/jimmunol.178.10.6115","article-title":"CD8+ T cells circumvent immune privilege in the eye and mediate intraocular tumor rejection by a TNF-alpha-dependent mechanism","volume":"178","author":"Dace","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"12","key":"10.1016\/j.mayocp.2018.11.033_bib36","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1167\/iovs.04-0599","article-title":"Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells","volume":"45","author":"He","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.mayocp.2018.11.033_bib37","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1172\/JCI42002","article-title":"Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma","volume":"120","author":"Eyles","year":"2010","journal-title":"J\u00a0Clin Invest"},{"issue":"20","key":"10.1016\/j.mayocp.2018.11.033_bib38","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2008.19.9919","article-title":"Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I\/II melanoma","volume":"27","author":"Jensen","year":"2009","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619300527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619300527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T20:41:44Z","timestamp":1569184904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619300527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0025619619300527"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.11.033","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}